G. Nyitrai et al., IN-VIVO BLOCKADE OF THALAMIC GABA(B) RECEPTORS INCREASES EXCITATORY AMINO-ACID LEVELS, European journal of pharmacology, 318(2-3), 1996, pp. 295-300
The effect of intrathalamic application of GABA(B) receptor antagonist
s on the basal excitatory amino-acid levels was studied using microdia
lysis probes implanted in the dorsal lateral geniculate nucleus and in
the ventrobasal complex. In both nuclei, continuous perfusion of the
GABA(B) receptor antagonist 3-aminopropyl-(diethoxymethyl)-phosphinic
acid (CGP 35348) produced an increase in the extracellular concentrati
on of aspartate and (to a lesser extent) glutamate, but no change was
observed in the level of taurine, the main amino acid involved in the
regulation of brain osmolarity processes. In contrast, mino-2-hydroxy-
2-(4-chlorophenyl)-propanesulphonic acid (2-hydroxy-saclofen), another
GABA(B) receptor antagonist, failed to affect the extracellular conce
ntration of aspartate, glutamate and taurine. Thus, the basal level of
excitatory amino acids in the thalamus in vivo is under the control o
f CGP 35348-sensitive GABA(B) receptors.